Rolling Returns
Poly Medicure Ltd.
Every 10-year stretch POLYMED has been through — 57 of them, each starting a month after the last. The median returned 32.2% a year, the worst 23.2%, the best 43.8%. A single headline CAGR hides all of that.
Every Holding Period
A rolling window is every possible start date, not one. A five-year window starting in January is a different investment from one starting in February, and over twenty years there are a couple of hundred of them. What follows is the full spread of what each holding period actually produced.
Across 165 separate 1-year holding periods, the median returned 34.4% a year. The worst lost 48.2% a year and the best made 337.3%.
Worst start: February 2015 — -48.2% a year for the 1 years that followed.
Best start: April 2020 — 337.3% a year.
Against the Nifty 50: POLYMED came out ahead in 61.2% of the 165 windows both series cover.
Across 141 separate 3-year holding periods, the median returned 35.1% a year. The worst lost 5.7% a year and the best made 103.4%.
Worst start: April 2017 — -5.7% a year for the 3 years that followed.
Best start: December 2011 — 103.4% a year.
Against the Nifty 50: POLYMED came out ahead in 79.4% of the 141 windows both series cover.
Across 117 separate 5-year holding periods, the median returned 33.6% a year. The worst lost 2.3% a year and the best made 70.0%.
Worst start: April 2015 — -2.3% a year for the 5 years that followed.
Best start: October 2019 — 70.0% a year.
Against the Nifty 50: POLYMED came out ahead in 89.7% of the 117 windows both series cover.
Across 93 separate 7-year holding periods, the median returned 31.9% a year. Not one of them ended in a loss — the weakest still compounded at 18.5% a year.
Worst start: July 2015 — 18.5% a year for the 7 years that followed.
Best start: August 2017 — 42.2% a year.
Against the Nifty 50: POLYMED came out ahead in 100.0% of the 93 windows both series cover.
Across 57 separate 10-year holding periods, the median returned 32.2% a year. Not one of them ended in a loss — the weakest still compounded at 23.2% a year.
Worst start: May 2016 — 23.2% a year for the 10 years that followed.
Best start: December 2011 — 43.8% a year.
Against the Nifty 50: POLYMED came out ahead in 100.0% of the 57 windows both series cover.
Windows step forward one month at a time and are measured on month-end adjusted closing prices, so dividends are treated as reinvested. Overlapping windows share months by construction — that is what makes the spread a description of this stock's history rather than a sample of independent trials.
Against The Index
Beating an index once is a result. Beating it across most of the periods an investor could have picked is a pattern. Over 10-year windows, POLYMED finished ahead of the Nifty 50 in 100.0% of the 57 periods both series cover.
1-year windows
Ahead in 61.2% of 165 periods.
3-year windows
Ahead in 79.4% of 141 periods.
5-year windows
Ahead in 89.7% of 117 periods.
7-year windows
Ahead in 100.0% of 93 periods.
10-year windows
Ahead in 100.0% of 57 periods.
Each window is compared against the index over the identical calendar months, on the same adjusted basis — not against an assumed rate of return.
How This Is Calculated
Windows step forward one month at a time, so they share most of their months with each other. That is what makes this a description of POLYMED's actual history rather than a set of independent trials — and why the spread should not be read as a probability.
Measured on month-end closing prices adjusted for dividends and splits, so dividends count as reinvested. A window that opened or closed mid-month would differ a little in either direction.
POLYMEDis in today's Nifty 500 universe. Companies that delisted or collapsed are not on this site at all, so the worst outcome shown here is the worst among the survivors.
Measured on data to 2026-08-31, from 2011-12-01. Full definitions are on our methodology page.
HELP CENTER
Everything you need to know about this page and the data presented.
Over 10 years, Poly Medicure Ltd. has been through 57 separate 10 years holding periods — one starting every month. The median returned 32.2% a year, the worst 23.2% and the best 43.8%. A rolling return measures every possible start date instead of one, which is why it answers a question a single headline CAGR cannot: how much the outcome depended on when you happened to buy.
No — not in any of the 57 10 years periods the record covers. The weakest of them still compounded at 23.2% a year. That is a statement about the past, not a guarantee about any future 10 years, and it is measured only over the years Poly Medicure Ltd. has been listed.
-2.3% a year, for the five years beginning April 2015. For contrast the best 5 years returned 70.0% a year, starting October 2019, and the median across all 117 periods was 33.6%. The gap between those two numbers is the part of the outcome that came down to timing rather than to the company.
On this record, yes. 1 year outcomes ranged from -48.2% to 337.3% a year — a spread of 385.6%. 10 years outcomes ranged from 23.2% to 43.8%, a spread of 20.6%. Longer holding periods narrowed the range of results, which is the usual pattern and the reason this page publishes every window rather than one. Narrowing the range is not the same as removing the risk.
In 100.0% of the 57 10 years periods both series cover. Each window is compared against the index over the identical months, not against an assumed index return, so the comparison is a like-for-like record rather than a model.
Windows step forward one month at a time on month-end closing prices adjusted for dividends and stock splits, so dividends are treated as reinvested. A window length is only published once there are at least twelve complete windows behind it — fewer than that describes an anecdote, not a distribution. Overlapping windows share months by construction, which is what makes this a description of the actual history of Poly Medicure Ltd. rather than a sample of independent trials. Companies that delisted are not on this site at all, a survivorship bias worth holding in mind.
That is not a question this page answers, and we do not make recommendations. What it can show you is the full range of what every holding period in the listed history of Poly Medicure Ltd. actually produced — including the worst ones, which most performance figures leave out. Those are records of what happened, not forecasts. A stock that never had a losing decade may still have one, and holding a single company is a materially different risk from holding an index.
Explore Further
POLYMED drawdowns and all-time high
The worst fall on record, how long recovery took, and how far the price sits below its peak.
POLYMED SIP returns
What a monthly investment would have produced, backtested rather than assumed.
POLYMED overview
Price history, wealth journey and how it compares with the index.
Rolling returns for every stock
Run the same question against any company we track.
ReturnScreener is an educational research platform and is not a SEBI-registered investment adviser. Everything on this page is a record of what historical prices did, not a projection and not a recommendation. Past performance does not guarantee future returns. See our methodology and disclaimer.